NEW YORK, April 5 (GenomeWeb News) - Shares in Ciphergen were down 27.24 percent, or $.67, at $1.79 in early-afternoon trading after the company said lackluster sales will cause first-quarter revenue to fall significantly short of earlier expectations.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.